ConductScience.org, home

Paper34845679

In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours.

Akanda M and 2 others. Drug Deliv Transl Res, 2023. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours. Papers, record 34845679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34845679

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours.
PubMed
Journal
Drug Deliv Transl Res
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
2.76
iCite
Revised in PubMed
2023-11-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Akanda MMushfiq
2Getti GGiulia
3Douroumis DDennishttps://orcid.org/0000-0002-3782-0091

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NanostructuresMajor topic
Prostatic NeoplasmsMajor topic
Male
Mice
Humans
Animals
Drug Carriers
Mice, Nude
Lipids
Particle Size

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133782898Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.Drug Deliv Transl Res2022https://conductscience.org/library/papers/33782898PubMed
225367836Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.Drug Deliv2016https://conductscience.org/library/papers/25367836PubMed
312753761Particle size of liposomes influences dermal delivery of substances into skin.Int J Pharm2003https://conductscience.org/library/papers/12753761PubMed
420553984The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.Biomaterials2010https://conductscience.org/library/papers/20553984PubMed
531773421Nanotechnology to improve the Alzheimer's disease therapy with natural compounds.Drug Deliv Transl Res2020https://conductscience.org/library/papers/31773421PubMed
621592751Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.Colloids Surf B Biointerfaces2011https://conductscience.org/library/papers/21592751PubMed
732924677Fabrication, optimisation and in vitro evaluation of docetaxel and curcumin Co-loaded nanostructured lipid carriers for improved antitumor activity against non-small cell lung carcinoma.J Microencapsul2020https://conductscience.org/library/papers/32924677PubMed
817543416Solid lipid nanoparticles as a drug delivery system for peptides and proteins.Adv Drug Deliv Rev2007https://conductscience.org/library/papers/17543416PubMed
916188405Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.Int J Pharm2005https://conductscience.org/library/papers/16188405PubMed
103042244Clinical pharmacokinetics of doxorubicin.Clin Pharmacokinet1988https://conductscience.org/library/papers/3042244PubMed
1120688493Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment.Colloids Surf B Biointerfaces2010https://conductscience.org/library/papers/20688493PubMed
1211967955Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation.Prostate2002https://conductscience.org/library/papers/11967955PubMed
1333895936Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.Drug Deliv Transl Res2022https://conductscience.org/library/papers/33895936PubMed
143139287Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate.Cancer Res1988https://conductscience.org/library/papers/3139287PubMed
1526162977A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.Colloids Surf B Biointerfaces2015https://conductscience.org/library/papers/26162977PubMed
1622609787Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics.Molecules2012https://conductscience.org/library/papers/22609787PubMed
1723116308Recent progress in studying curcumin and its nano-preparations for cancer therapy.Curr Pharm Des2013https://conductscience.org/library/papers/23116308PubMed
1820938993Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.Mol Nutr Food Res2011https://conductscience.org/library/papers/20938993PubMed
1931942699Thermo-reversible in situ forming implant with nanostructured lipid carriers (NLC) as a delivery system for the administration of estradiol valerate.Drug Deliv Transl Res2020https://conductscience.org/library/papers/31942699PubMed
2031060404Fabrication, optimization, and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity.J Liposome Res2020https://conductscience.org/library/papers/31060404PubMed

See all 32 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42076126BSA-Based Nanoparticles for Dual Loading of Pazopanib and Enzalutamide: Formulation Optimization and In Vitro Evaluation in Breast Cancer Cells.Pharmaceutics2026https://conductscience.org/library/papers/42076126PubMed
41908436Chemosensitizer Effects of Coencapsulation of Curcumin and Cabazitaxel in Nanostructured Lipid Carriers in Glioblastoma Cells.ACS Omega2026https://conductscience.org/library/papers/41908436PubMed
41661421Smart nanoparticle delivery systems for curcumin: a targeted strategy to enhance anticancer efficacy and bioavailability.J Mater Sci Mater Med2026https://conductscience.org/library/papers/41661421PubMed
40370243Advances and Future Prospects of Lipid-Based Nanocarriers in Targeted Cancer Therapy: A Comprehensive Review.Curr Cancer Drug Targets2026https://conductscience.org/library/papers/40370243PubMed
39738884Enhancement of cannabidiol oral bioavailability through the development of nanostructured lipid carriers: In vitro and in vivo evaluation studies.Drug Deliv Transl Res2025https://conductscience.org/library/papers/39738884PubMed
37768530QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies.Drug Deliv Transl Res2024https://conductscience.org/library/papers/37768530PubMed
37630208Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine.Molecules2023https://conductscience.org/library/papers/37630208PubMed
37514275From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds.Plants (Basel)2023https://conductscience.org/library/papers/37514275PubMed
37157192Recent Advances in Nanocarrier-based Approaches to Atopic Dermatitis and Emerging Trends in Drug Development and Design.Curr Drug Deliv2024https://conductscience.org/library/papers/37157192PubMed
36986748Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers.Pharmaceutics2023https://conductscience.org/library/papers/36986748PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34845679

GET https://conductscience.org/api/papers/v1/34845679/references?page=2